Cited by 1,434Obstructive Sleep Apnea ResearchApelin-related biomedical researchNeuroscience of respiration and sleep

Sleep Apnea

Open access
Javaheri, Shahrokh, Barbe, Ferran, Campos-Rodriguez, Francisco, Dempsey, Jerome A., Khayat, Rami, Javaheri, Sogol, Malhotra, Atul, Martinez-Garcia, Miguel A. +5 more·2017·Journal of the American College of Cardiology

Abstract

Sleep apnea is highly prevalent in patients with cardiovascular disease. These disordered breathing events are associated with a profile of perturbations that include intermittent hypoxia, oxidative stress, sympathetic activation, and endothelial dysfunction, all of which are critical mediators of cardiovascular disease. Evidence supports a causal association of sleep apnea with the incidence and morbidity of hypertension, coronary heart disease, arrhythmia, heart failure, and stroke. Several discoveries in the pathogenesis, along with developments in the treatment of sleep apnea, have accumulated in recent years. In this review, we discuss the mechanisms of sleep apnea, the evidence that addresses the links between sleep apnea and cardiovascular disease, and research that has addressed the effect of sleep apnea treatment on cardiovascular disease and clinical endpoints. Finally, we review the recent development in sleep apnea treatment options, with special consideration of treating patients with heart disease. Future directions for selective areas are suggested.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2016.11.069

Cites

122 of 122 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In a meta-analysis of 2,570 patients with heart failure with reduced ejection fraction and moderate to severe sleep apnea, central sleep apnea was the dominant phenotype in more than 70% of cases.

    “However, in a meta-analysis of 2570 patients with HF with reduced ejection fraction and moderate to severe sleep apnea, CSA represented the dominant phenotype in >70% of cases.4”

    From Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association (2021) · cites this paper as [4]

    The section “Prevalence of Sleep Apnea in HFrEF, HFpEF, and Acute HF” reports CSA as more common than OSA in two HFrEF groups totaling 2,570 patients; its figures imply roughly 70% CSA among those with moderate-to-severe sleep apnea. But 2,570 is the total number of HFrEF patients, not the number with moderate-to-severe sleep apnea, and the review does not describe these groups as one meta-analysis. No page number is available in our copy. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • There is a need for additional treatment options for obstructive sleep apnea because patients are sometimes unable or unwilling to adhere to PAP treatment and PAP has not been shown to affect cardiovascular complications and death.

    “Patients with obstructive sleep apnea are sometimes unable or unwilling to adhere to PAP treatment, and PAP has not been shown to affect cardiovascular complications and death in obstructive sleep apnea; therefore, there is a need for additional treatment options. 4-6,10”

    From Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (2024) · cites this paper as [10]

    The CPAP, CHD, CV Mortality, and Composite CV Outcomes section reports no significant reduction in the primary composite cardiovascular outcomes of three randomized trials. Future Directions identifies poor adherence as a major trial limitation and discusses alternatives to CPAP. The claim is too broad about cardiovascular complications and death: the paper also reports observational evidence of improved survival and cardiovascular benefits among patients who used CPAP for at least four hours per night. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • Obstructive sleep apnea and obesity are two distinct but closely related diseases, and both have independent etiologic roles in the development of cardiovascular complications.

    “Obstructive sleep apnea and obesity are two distinct but closely related diseases, and both have independent etiologic roles in the development of cardiovascular complications. 10”

    From Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (2024) · cites this paper as [10]

    The Pathogenesis of OSA section identifies obesity as a major risk factor for OSA, while the opening discussion identifies OSA as a cardiovascular risk factor. The Molecular Signatures section reports that weight loss and CPAP each reduced blood pressure in obese patients, but cautions that disentangling obesity’s effects from OSA’s is difficult. It does not establish independent etiologic roles for both across cardiovascular complications generally. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • Among adverse cardiovascular consequences, the evidence linking OSA and hypertension is the most robust.

    “While OSA has been associated with several adverse CV consequences, the evidence linking OSA and HTN is the most robust.680,681”

    From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [680]

  • Large swings in intrathoracic pressure due to inspiratory effort against a closed upper airway exert transmural pressures across the heart and great vessels, leading to increased afterload, reduced stroke volume, and increased myocardial oxygen consumption.

    “Additionally, large swings in intrathoracic pressure due to inspiratory effort against a closed UA exert transmural pressures across the heart and great vessels, leading to increasing afterload, reduced stroke volume and increased myocardial oxygen consumption.680”

    From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [680]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

4 of the 126 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. [106]Javaheri S Brown LK Randerath WJ Positive airway pressure therapy with adaptive servoventilation: part 1: operational algorithms Chest 2014 146 514 23 25091757

Cited by

Sorted by citations

Authors
Javaheri, S., Barbe, F., Campos-Rodriguez, F., Dempsey, J. A., Khayat, R., Javaheri, S., Malhotra, A., Martinez-Garcia, M. A., Mehra, R., Pack, A. I., Polotsky, V. Y., Redline, S., & Somers, V. K.
Affiliations
  • Brigham and Women's Hospital (US)
  • University of Wisconsin–Madison (US)
  • The Ohio State University (US)
  • University of California San Diego (US)
  • Cleveland Clinic Lerner College of Medicine (US)
  • University of Pennsylvania (US)
  • Johns Hopkins University (US)
  • Mayo Clinic (US)
Corresponding author
Javaheri, Shahrokh
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2017-02
Volume
69
Issue
7
Pages
841-858
ISSN
0735-1097 (ISSN-L)
OpenAlex
W2592857683
Cited by
1,434
References
126
Citations by year
2026: 166 · 2025: 169 · 2024: 183 · 2023: 202 · 2022: 172 · 2021: 160 · 2020: 129 · 2019: 111 · 2018: 92 · 2017: 45 · 2014: 1 · 2013: 1 · 2012: 1
FWCI
12.65
Type
journal article
Language
en
Open access
Locations
  • Journal of the American College of Cardiology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • RISalud Institutional Health Repository of Andalucía (submittedVersion, other-oa)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • Ohio State University
  • ResMed
  • Respicardia
  • National Heart, Lung, and Blood Institute (R01HL128970, T32HL134632, R01HL085188, K24HL132105, R01HL133100)
  • National Institute of Environmental Health Sciences (P50ES018176)
Topics
  • Health Sciences › Medicine › Physiology › Obstructive Sleep Apnea Research
  • Health Sciences › Medicine › Pharmacology › Apelin-related biomedical research
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroscience of respiration and sleep
Keywords
sleep apnea, cardiovascular disease, intermittent hypoxia, oxidative stress, sympathetic activation, endothelial dysfunction, hypertension, coronary artery disease, cardiac arrhythmias, heart failure, stroke, sleep apnea treatment, cardiac patients
MeSH terms
Cardiovascular Diseases, Humans, Sleep Apnea Syndromes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review